Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Francoise Huguet-Rigal"'
Autor:
Tove Flem Jacobsen, Norbert Vey, Athos Gianella-Borradori, Thomas Kindler, Trygve Bergeland, Juergen Krauter, David A. Rizzieri, Xavier Thomas, Bjørn Tore Gjertsen, Francoise Huguet-Rigal, Igor Wolfgang Blau, Utz Krug, Malin Johansen, Richard F. Schlenk
Publikováno v:
Leukemialymphoma. 55(9)
Unlike cytarabine, cellular entry of Elacytarabine, the elaidic acid ester derivative of cytarabine, is independent of the human equilibrative nucleoside transporter 1 (hENT1). This phase II study tested whether the hENT1 blast expression level can b
Autor:
Elizabeth Macintyre, Francis Witz, Eric Delabesse, Arnaud Pigneux, Martine Escoffre, Philippe Rousselot, Véronique Lhéritier, Jean-Michel Cayuela, Yves Chalandon, M C Vekemans, Delphine Rea, Oumedaly Reman, Norbert Ifrah, Xavier Thomas, Jean-Paul Vernant, Sébastien Maury, Adrienne de Labarthe, Francoise Huguet-Rigal, Hervé Dombret, Agnes Buzyn
Publikováno v:
Blood, Vol. 109, No 4 (2007) pp. 1408-13
The combination of imatinib with chemotherapy has been recently reported as very promising in patients with Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL). During 2004 and 2005, 45 patients with newly diagnosed Ph+ ALL we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d010f8c8c434d034f5ccc9840aff543
https://archive-ouverte.unige.ch/unige:26015
https://archive-ouverte.unige.ch/unige:26015
Autor:
Cécile Pautas, Xavier Thomas, Francoise Huguet-Rigal, Jean-Michel Cayuela, Jean Gabert, Hervé Dombret, Nathalie Fegueux, Véronique Lhéritier, Philippe Rousselot, André Baruchel, Nicolas Boissel, Christian Berthou, Marie-Françoise Auclerc, Denis Fiere, Jean-Michel Boiron, Christophe Piguet, Gérard Michel, Thierry Leblanc, Guy Leverger, Yves Perel
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 21(5)
Purpose: To compare pediatric and adult therapeutic practices in the treatment of acute lymphoblastic leukemia (ALL) in adolescents. Patients and Methods: From June 1993 to September 1994, 77 and 100 adolescents (15 to 20 years of age) were enrolled
Autor:
Sandrine Hayette, Tibor Kovacsovics, Jean-Michel Cayuela, Elizabeth Macintyre, Amel Ouslimani, Eric Delabesse, Hervé Dombret, Jean Gabert, Claude Preudhomme, André Delannoy, Jean-Paul Vernant, Francoise Huguet-Rigal, Anne Vekhoff, Norbert Vey, Francis Witz, Charles Dauriac, Elodie Soler, Stéphane de Botton, Xavier Thomas
Publikováno v:
ResearcherID
Publons
Publons
In a large series of patients with Ph1-ALL treated in the LALA-94 trial, negative BCR-ABL minimal residual disease (MRD) and allogeneic donor availability were two independent good-risk factors for survival in those reaching hematological complete re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e2f4f93f0db51ef5eb438f2aef26bbc
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000225127502742&KeyUID=WOS:000225127502742
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000225127502742&KeyUID=WOS:000225127502742